PV-kardiologie s.r.o.
- Address
- Rokycanova 2798, 530 02 Pardubice, Czechia
PV-kardiologie s.r.o. - Cardiovascular Research Center
PV-kardiologie s.r.o. is a specialized cardiovascular research facility dedicated to advancing the understanding and treatment of cardiac arrhythmias and associated conditions. The center focuses on evaluating novel anticoagulation therapies and their safety profiles in patients with complex cardiac rhythm disorders.
- Atrial fibrillation management and anticoagulation strategies
- Comparative safety studies of novel oral anticoagulants
- Bleeding risk assessment in cardiac arrhythmia patients
The research center actively participates in pivotal clinical trials examining next-generation therapeutic options for patients with atrial fibrillation, particularly focusing on optimizing the balance between stroke prevention and bleeding risk reduction. Their work contributes to evidence-based approaches for managing anticoagulation in populations with irregular heart rhythms, helping to establish safer treatment protocols for cardiovascular patients requiring long-term anticoagulation therapy.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in PV-kardiologie s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of the Safety and Tolerability of Abelacimab Versus Rivaroxaban in Patients with Atrial Fibrillation: A Randomized Controlled Trial | Anthos Therapeutics Inc. | Phase II | Not Recruiting | Apr 2021 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abelacimab | 1 | Unknown | 2021-04-16 | 2021-04-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.